| Biogen | 266.6000 / -1.20% |
| Date/Time | 03/03 / 22:00 |
| Chg. / Chg.(%) | -3.2500 / -1.20% |
| Bid | 265.8100 / 1000 |
| Ask | 272.9800 / 100 |
| Open | 267.8000 |
| Previous Close | 269.8500 |
| High | 269.2800 |
| Low | 263.8000 |
| Volume [USD] | 156,447,424.6185 |
| Volume [Units] | 1,037,052 |
| Price fixings | 4126 |
| ISIN | US09062X1037 |
| Security | BIIB |
| Exchange | NASDAQ |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| TradeGate | 221.450 |  |
458 |
| Xetra | 221.10 | |
248 |
| Moscow | 19,620.00 |  |
162 |
| Stuttgart | 219.750 | |
100 |
| gettex | 220.600 | |
16 |
| Vienna Globa.. | 221.35 | |
5 |
| Frankfurt | 220.1000 | |
2 |
| München | 218.95 | |
0 |
| Hamburg | 219.55 | |
0 |
| Düsseldorf | 221.35 | |
0 |
| Berlin | 221.35 | |
0 |
| Hannover | 219.55 | |
0 |
| Lang & Schwa.. | 221.300 | |
|
| NASDAQ | 266.6000 | |
1,037,052 |
| IEX | 266.52 | |
57,154 |
| Cboe US | 266.81 | 46,672 | |
| London Inter.. | 267.40 | 1,103 | |
| Mexico | 5,588.99 | |
200 |
News
- Catalyst Biosciences Reports Fourth Quarter and Full-Year 2020 Operating & Financial Results and Provides a Corporate Update
14:00 - GlobeNewswire - Biogen Announces Plans to Build a New, State-of-the-Art Gene Therapy Manufacturing Facility in Research Triangle Park, North Carolina
13:47 - GlobeNewswire - Dyne Therapeutics Appoints Wildon Farwell, M.D., MPH, as Chief Medical Officer
13:25 - GlobeNewswire - Purple Biotech Appoints Biopharmaceutical Industry Veteran Robert Gagnon to Board of Directors
03/03/2021 / 13:00 - GlobeNewswire - Artizan Biosciences Closes $11 Million Series A-2 Financing and Enters Option and License Agreement with Biohaven Therapeutics
03/01/2021 / 22:00 - GlobeNewswire
Real-time